BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Retained Earnings (2018 - 2026)

BiomX's (PHGE) quarterly Retained Earnings came in at $244.5 million in Q2 2026, up 25.43% year-over-year from $194.9 million in Q2 2025, and up 203.57% quarter-over-quarter from -$236.0 million in Q1 2026.

Analysis

BiomX (PHGE) Retained Earnings (2018 - 2026) Analysis & Trends

BiomX has disclosed Retained Earnings across 9 years of filings, most recently posting $244.5 million for Q2 2026.

  • In Q2 2026, Retained Earnings rose 25.43% year-over-year to $244.5 million; the TTM figure through Jun 2026 stood at $244.5 million (up 25.43% YoY), while the FY2025 annual figure was -$216.9 million, down 216.49% from the prior year.
  • Retained Earnings came in at $244.5 million for Q2 2026 at BiomX, up from -$236.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $244.5 million in Q2 2026 to a low of -$236.0 million in Q1 2026.
  • Average Retained Earnings over 5 years is $85.8 million, with a median of $159.3 million recorded in 2023.
  • Year-over-year, Retained Earnings surged 210.85% in 2025 and tumbled 221.54% in 2026.
  • Over 5 years, Retained Earnings stood at $157.8 million in 2022, then gained by 5.2% to $166.0 million in 2023, then advanced by 12.13% to $186.2 million in 2024, then sank by 216.49% to -$216.9 million in 2025, then soared by 212.71% to $244.5 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were $244.5 million in Q2 2026, -$236.0 million in Q1 2026, and -$216.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 558.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 20.97 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.57 Bn
10 BiomX 1.55 Mn 7.73 Mn 97,000.00 244.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244.47 Mn
Mar 31, 2026 -236.04 Mn
Dec 31, 2025 -216.90 Mn
Sep 30, 2025 -203.56 Mn
Jun 30, 2025 194.90 Mn
Mar 31, 2025 194.20 Mn
Dec 31, 2024 186.19 Mn
Sep 30, 2024 185.43 Mn
Jun 30, 2024 -175.83 Mn
Dec 31, 2023 166.05 Mn
Sep 30, 2023 165.63 Mn
Jun 30, 2023 165.44 Mn
Mar 31, 2023 159.31 Mn
Dec 31, 2022 157.84 Mn
Sep 30, 2022 157.47 Mn
Jun 30, 2022 156.87 Mn
Mar 31, 2022 156.67 Mn
Dec 31, 2021 156.02 Mn
Sep 30, 2021 151.45 Mn
Jun 30, 2021 136.59 Mn